These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

135 related articles for article (PubMed ID: 4850366)

  • 1. Abnormalities in clotting and thrombolysis as a risk factor for stroke.
    Pilgeram LO
    Thromb Diath Haemorrh; 1974 May; 31(2):245-64. PubMed ID: 4850366
    [No Abstract]   [Full Text] [Related]  

  • 2. Evidence for abnormalities in clotting and thrombolysis as a risk factor for stroke.
    Pilgeram LO; Chee AN; Von dem Bussche G
    Stroke; 1973; 4(4):643-57. PubMed ID: 4723694
    [No Abstract]   [Full Text] [Related]  

  • 3. [Respiratory distress syndrome and disseminated intravasal clotting].
    Künzer W; Karitzky D; Pringsheim W
    Dtsch Med Wochenschr; 1970 Oct; 95(42):2141-4. PubMed ID: 5507466
    [No Abstract]   [Full Text] [Related]  

  • 4. The role of coagulation in renal disease.
    MacDonald MK; Clarkson AR; Davison AM
    Perspect Nephrol Hypertens; 1973; 1 Pt 2(0):809-28. PubMed ID: 4807810
    [No Abstract]   [Full Text] [Related]  

  • 5. Depressed endogenous fibrinolytic activity in essential hypertension.
    Tsapogas MJ; Peabody RA; Wu KT; Devaraj KT; Eckert C
    J Cardiovasc Surg (Torino); 1974; 15(6):651-4. PubMed ID: 4281429
    [No Abstract]   [Full Text] [Related]  

  • 6. [Fibrinolysis, determination and interpretation].
    Maki M
    Rinsho Byori; 1970 Aug; 18(8):563-8. PubMed ID: 5466550
    [No Abstract]   [Full Text] [Related]  

  • 7. Fibrin breakdown products and fibrinolysis in renal disease.
    Wardle EN; Taylor G
    J Clin Pathol; 1968 Mar; 21(2):140-6. PubMed ID: 5697045
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Blood coagulation, fibrinolytic activity and lipid profile in subclinical thyroid disease: subclinical hyperthyroidism increases plasma factor X activity.
    Erem C
    Clin Endocrinol (Oxf); 2006 Mar; 64(3):323-9. PubMed ID: 16487444
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Blood coagulation and fibrinolysis in a random sample of 788 men 54 years old. II. Relations of the variables to "risk factors" for myocardial infarction.
    Korsan-Bengtsen K; Wilhelmsen L; Tibblin G
    Thromb Diath Haemorrh; 1972 Aug; 28(1):99-108. PubMed ID: 5074994
    [No Abstract]   [Full Text] [Related]  

  • 10. The defibrination syndrome in rabbits following infusion of tissue thromboplastin in the jugular vein.
    Albrechtsen OK; Brakman P; Astrup T
    Thromb Diath Haemorrh; 1970 Oct; 24(1):113-28. PubMed ID: 5483954
    [No Abstract]   [Full Text] [Related]  

  • 11. [Studies on fibrinolysis in equivalents of the Sanarelli-Shwartzman phenomenon in obstetrics. Immunochemical demonstration of derivatives of fibrin(ogen)].
    Steichele DF; Herschlein HJ
    Thromb Diath Haemorrh; 1967 Dec; 18(3-4):462-74. PubMed ID: 5590239
    [No Abstract]   [Full Text] [Related]  

  • 12. Blood coagulation and fibrinolysis in a random sample of 788 men 54 years old. I. Correlations between the variables of clotting and fibrinolysis.
    Korsan-Bengtsen K; Wilhelmsen L; Tibblin G
    Thromb Diath Haemorrh; 1972 Aug; 28(1):89-98. PubMed ID: 5074993
    [No Abstract]   [Full Text] [Related]  

  • 13. [Changes of coagulation after acute apoplectic strokes (author's transl)].
    Rompel K; Pfeiffer H; Höbel W; Heene DL
    Med Klin; 1973 Dec; 68(52):1729-32. PubMed ID: 4786597
    [No Abstract]   [Full Text] [Related]  

  • 14. Split products of fibrin in maternal serum in the perinatal period.
    Stiehm ER; Kennan AL; Schelble DT
    Am J Obstet Gynecol; 1970 Nov; 108(6):941-5. PubMed ID: 5486486
    [No Abstract]   [Full Text] [Related]  

  • 15. [Alterations of fibrinolysis in stroke].
    Hernández Nuñez A; Romero Barbero JL; Cáceres Sansaloni A; Pérez de Oteyza C
    An Med Interna; 1996 Mar; 13(3):107-10. PubMed ID: 8679836
    [TBL] [Abstract][Full Text] [Related]  

  • 16. [Differential diagnosis between primary and secondary hyperfibrinolysis].
    Heene DL
    Folia Haematol Int Mag Klin Morphol Blutforsch; 1970; 94(2):186-94. PubMed ID: 4098772
    [No Abstract]   [Full Text] [Related]  

  • 17. Blood coagulation and fibrinolysis in obese NIDDM patients.
    Avellone G; Di Garbo V; Cordova R; Rotolo G; Abruzzese G; Raneli G; De Simone R; Bompiani GD
    Diabetes Res; 1994; 25(2):85-92. PubMed ID: 7648783
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Inherited fibrinolytic disorder due to an enhanced plasminogen activator level.
    Aznar J; Estellés A; Vila V; Regañón E; España F; Villa P
    Thromb Haemost; 1984 Oct; 52(2):196-200. PubMed ID: 6543037
    [TBL] [Abstract][Full Text] [Related]  

  • 19. [Immunoelectrophoretic study of fibrinogen and of degradation products of fibrinogen and fibrin].
    Karpinskaia VM
    Probl Gematol Pereliv Krovi; 1968 Jan; 13(1):53-6. PubMed ID: 5736826
    [No Abstract]   [Full Text] [Related]  

  • 20. Fibrin-degradation products in cerebral malaria.
    Reid HA; Nkrumah FK
    Lancet; 1972 Jan; 1(7744):218-21. PubMed ID: 4109696
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 7.